Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 17 | 2025 | 2218 | 2.910 |
Why?
|
| Gangliosidosis, GM1 | 3 | 2026 | 24 | 1.320 |
Why?
|
| Brain | 7 | 2026 | 1581 | 1.160 |
Why?
|
| Endovascular Procedures | 4 | 2024 | 607 | 1.130 |
Why?
|
| Brain Ischemia | 3 | 2025 | 421 | 1.030 |
Why?
|
| Stroke | 2 | 2023 | 1196 | 0.800 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2025 | 87 | 0.790 |
Why?
|
| Genetic Therapy | 7 | 2026 | 799 | 0.720 |
Why?
|
| ErbB Receptors | 2 | 2013 | 118 | 0.720 |
Why?
|
| Glioma | 2 | 2013 | 100 | 0.710 |
Why?
|
| Disease Models, Animal | 6 | 2025 | 2237 | 0.650 |
Why?
|
| Intestines | 1 | 2021 | 169 | 0.630 |
Why?
|
| Intracranial Aneurysm | 2 | 2023 | 374 | 0.590 |
Why?
|
| Collagen | 1 | 2019 | 124 | 0.570 |
Why?
|
| Kyphosis | 1 | 2018 | 6 | 0.560 |
Why?
|
| Achondroplasia | 1 | 2018 | 2 | 0.560 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2018 | 5 | 0.560 |
Why?
|
| Tay-Sachs Disease | 3 | 2025 | 46 | 0.560 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 84 | 0.550 |
Why?
|
| Spine | 1 | 2018 | 50 | 0.540 |
Why?
|
| Hyaluronic Acid | 1 | 2018 | 70 | 0.540 |
Why?
|
| Blood Vessels | 1 | 2017 | 63 | 0.530 |
Why?
|
| Animals | 19 | 2025 | 20955 | 0.510 |
Why?
|
| Hydrogels | 1 | 2018 | 119 | 0.500 |
Why?
|
| Contrast Media | 3 | 2015 | 429 | 0.490 |
Why?
|
| Genetic Vectors | 6 | 2026 | 887 | 0.440 |
Why?
|
| Biomimetics | 1 | 2014 | 31 | 0.420 |
Why?
|
| Liposomes | 1 | 2014 | 107 | 0.410 |
Why?
|
| Organometallic Compounds | 1 | 2014 | 71 | 0.410 |
Why?
|
| Neuroprotective Agents | 1 | 2014 | 77 | 0.410 |
Why?
|
| Neuroimaging | 2 | 2025 | 155 | 0.410 |
Why?
|
| Molecular Imaging | 1 | 2013 | 52 | 0.400 |
Why?
|
| Superoxide Dismutase | 1 | 2014 | 226 | 0.380 |
Why?
|
| Coordination Complexes | 1 | 2012 | 10 | 0.380 |
Why?
|
| Thalamus | 2 | 2025 | 75 | 0.380 |
Why?
|
| Cerebral Angiography | 3 | 2023 | 295 | 0.370 |
Why?
|
| Manganese Compounds | 1 | 2012 | 8 | 0.370 |
Why?
|
| Peroxidase | 1 | 2012 | 70 | 0.370 |
Why?
|
| Chlorides | 1 | 2012 | 31 | 0.360 |
Why?
|
| Dogs | 3 | 2025 | 332 | 0.360 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 296 | 0.350 |
Why?
|
| Brain Neoplasms | 2 | 2013 | 313 | 0.350 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2025 | 677 | 0.340 |
Why?
|
| Tomography, Optical Coherence | 2 | 2024 | 227 | 0.340 |
Why?
|
| Humans | 25 | 2026 | 64272 | 0.320 |
Why?
|
| Dependovirus | 6 | 2026 | 718 | 0.310 |
Why?
|
| beta-Galactosidase | 2 | 2026 | 84 | 0.280 |
Why?
|
| Disease Progression | 2 | 2025 | 1174 | 0.270 |
Why?
|
| Child, Preschool | 4 | 2026 | 2019 | 0.270 |
Why?
|
| White Matter | 2 | 2025 | 123 | 0.260 |
Why?
|
| Male | 14 | 2026 | 30322 | 0.260 |
Why?
|
| Cerebrovascular Circulation | 2 | 2025 | 183 | 0.250 |
Why?
|
| Female | 13 | 2026 | 33383 | 0.250 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2023 | 288 | 0.250 |
Why?
|
| Cattle | 2 | 2019 | 316 | 0.240 |
Why?
|
| Infant | 3 | 2025 | 1664 | 0.240 |
Why?
|
| Treatment Outcome | 4 | 2026 | 5696 | 0.240 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2025 | 1 | 0.230 |
Why?
|
| Phenylketonurias | 1 | 2025 | 2 | 0.230 |
Why?
|
| Gray Matter | 1 | 2025 | 38 | 0.230 |
Why?
|
| Gangliosidoses, GM2 | 1 | 2025 | 19 | 0.230 |
Why?
|
| Respiration | 2 | 2017 | 92 | 0.230 |
Why?
|
| Phenylalanine | 1 | 2025 | 26 | 0.230 |
Why?
|
| Sandhoff Disease | 1 | 2025 | 36 | 0.230 |
Why?
|
| Solubility | 2 | 2018 | 189 | 0.230 |
Why?
|
| Mice | 8 | 2025 | 10994 | 0.220 |
Why?
|
| Atrophy | 1 | 2025 | 87 | 0.220 |
Why?
|
| Neurofibromin 1 | 1 | 2024 | 14 | 0.220 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 625 | 0.210 |
Why?
|
| Rats | 3 | 2013 | 2005 | 0.210 |
Why?
|
| Neurofibromatosis 1 | 1 | 2024 | 31 | 0.210 |
Why?
|
| Codon, Nonsense | 1 | 2024 | 58 | 0.210 |
Why?
|
| Cerebral Arteries | 1 | 2024 | 40 | 0.210 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2017 | 202 | 0.210 |
Why?
|
| Mice, Inbred DBA | 2 | 2014 | 85 | 0.200 |
Why?
|
| Child | 4 | 2026 | 4583 | 0.200 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2025 | 155 | 0.200 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2023 | 14 | 0.200 |
Why?
|
| Oligodendroglia | 2 | 2025 | 36 | 0.200 |
Why?
|
| Myelin Sheath | 2 | 2025 | 37 | 0.190 |
Why?
|
| Models, Anatomic | 1 | 2023 | 63 | 0.190 |
Why?
|
| Carotid Artery, Internal | 1 | 2023 | 68 | 0.190 |
Why?
|
| Rats, Nude | 2 | 2013 | 24 | 0.190 |
Why?
|
| Robotic Surgical Procedures | 1 | 2025 | 162 | 0.190 |
Why?
|
| Neurosurgical Procedures | 1 | 2023 | 101 | 0.180 |
Why?
|
| Infarction | 1 | 2022 | 20 | 0.180 |
Why?
|
| Rabbits | 1 | 2022 | 333 | 0.180 |
Why?
|
| Mutation | 3 | 2018 | 2633 | 0.180 |
Why?
|
| Case-Control Studies | 1 | 2025 | 1131 | 0.180 |
Why?
|
| Radial Artery | 1 | 2022 | 54 | 0.180 |
Why?
|
| Mice, Transgenic | 3 | 2024 | 1297 | 0.180 |
Why?
|
| Thrombectomy | 1 | 2023 | 241 | 0.170 |
Why?
|
| Demography | 1 | 2021 | 174 | 0.170 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 215 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 3449 | 0.160 |
Why?
|
| Cell Line, Tumor | 3 | 2015 | 1494 | 0.160 |
Why?
|
| Oxygen | 1 | 2022 | 321 | 0.160 |
Why?
|
| Injections | 1 | 2020 | 82 | 0.160 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2021 | 99 | 0.160 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 197 | 0.150 |
Why?
|
| Weight Loss | 1 | 2021 | 276 | 0.150 |
Why?
|
| Implants, Experimental | 1 | 2019 | 5 | 0.150 |
Why?
|
| Movement | 2 | 2017 | 161 | 0.150 |
Why?
|
| Stents | 1 | 2022 | 492 | 0.140 |
Why?
|
| Computer Simulation | 2 | 2017 | 482 | 0.140 |
Why?
|
| Myelin Basic Protein | 1 | 2018 | 21 | 0.140 |
Why?
|
| X-Ray Microtomography | 1 | 2018 | 26 | 0.140 |
Why?
|
| Antibodies, Monoclonal | 2 | 2013 | 870 | 0.140 |
Why?
|
| Diffusion | 1 | 2017 | 82 | 0.140 |
Why?
|
| Luciferases | 1 | 2018 | 108 | 0.140 |
Why?
|
| Cross-Linking Reagents | 1 | 2018 | 117 | 0.140 |
Why?
|
| Monte Carlo Method | 1 | 2017 | 90 | 0.130 |
Why?
|
| Adolescent | 2 | 2025 | 6306 | 0.130 |
Why?
|
| Chelating Agents | 2 | 2018 | 51 | 0.130 |
Why?
|
| Optical Imaging | 1 | 2018 | 74 | 0.130 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2017 | 51 | 0.120 |
Why?
|
| Heart | 2 | 2017 | 287 | 0.120 |
Why?
|
| Photoacoustic Techniques | 1 | 2015 | 4 | 0.120 |
Why?
|
| Dextrans | 1 | 2015 | 45 | 0.120 |
Why?
|
| Ferric Compounds | 1 | 2015 | 44 | 0.120 |
Why?
|
| Survival Rate | 1 | 2018 | 859 | 0.120 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 749 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 685 | 0.110 |
Why?
|
| Young Adult | 1 | 2025 | 4782 | 0.110 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2014 | 101 | 0.110 |
Why?
|
| Manganese | 1 | 2014 | 22 | 0.110 |
Why?
|
| Retrospective Studies | 2 | 2023 | 6741 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 1213 | 0.100 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 136 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2025 | 1682 | 0.100 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 220 | 0.100 |
Why?
|
| Gold | 1 | 2015 | 233 | 0.100 |
Why?
|
| 5-Hydroxytryptophan | 1 | 2012 | 3 | 0.100 |
Why?
|
| Pentetic Acid | 1 | 2012 | 33 | 0.100 |
Why?
|
| Gene Transfer Techniques | 2 | 2025 | 322 | 0.100 |
Why?
|
| Blood Proteins | 1 | 2012 | 80 | 0.090 |
Why?
|
| Drug Stability | 1 | 2012 | 144 | 0.090 |
Why?
|
| Metabolic Clearance Rate | 1 | 2012 | 49 | 0.090 |
Why?
|
| Antioxidants | 1 | 2014 | 256 | 0.090 |
Why?
|
| Injections, Subcutaneous | 1 | 2012 | 69 | 0.090 |
Why?
|
| Gadolinium | 1 | 2012 | 110 | 0.090 |
Why?
|
| Motion | 2 | 2025 | 62 | 0.090 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 327 | 0.090 |
Why?
|
| Tissue Distribution | 1 | 2012 | 296 | 0.090 |
Why?
|
| Horseradish Peroxidase | 1 | 2011 | 15 | 0.090 |
Why?
|
| Adult | 2 | 2025 | 17136 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 462 | 0.080 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 167 | 0.080 |
Why?
|
| Kinetics | 1 | 2012 | 766 | 0.080 |
Why?
|
| Time Factors | 1 | 2018 | 3725 | 0.080 |
Why?
|
| Gadolinium DTPA | 1 | 2011 | 84 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 240 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 869 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2015 | 523 | 0.080 |
Why?
|
| Image Enhancement | 1 | 2011 | 193 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 248 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 746 | 0.070 |
Why?
|
| G(M1) Ganglioside | 1 | 2026 | 12 | 0.060 |
Why?
|
| Aspartate Aminotransferases | 1 | 2026 | 35 | 0.060 |
Why?
|
| Alanine Transaminase | 1 | 2026 | 45 | 0.060 |
Why?
|
| Red Nucleus | 1 | 2025 | 5 | 0.060 |
Why?
|
| Basal Ganglia | 1 | 2025 | 34 | 0.060 |
Why?
|
| beta-Hexosaminidase alpha Chain | 1 | 2025 | 14 | 0.060 |
Why?
|
| Infusions, Intravenous | 1 | 2026 | 176 | 0.060 |
Why?
|
| Abdomen | 2 | 2017 | 94 | 0.060 |
Why?
|
| Collateral Circulation | 1 | 2025 | 26 | 0.060 |
Why?
|
| Thalamic Nuclei | 1 | 2025 | 25 | 0.060 |
Why?
|
| Amygdala | 1 | 2025 | 84 | 0.060 |
Why?
|
| Corpus Callosum | 1 | 2025 | 42 | 0.060 |
Why?
|
| Artifacts | 2 | 2017 | 127 | 0.060 |
Why?
|
| Oxadiazoles | 1 | 2024 | 8 | 0.050 |
Why?
|
| Miniaturization | 1 | 2024 | 10 | 0.050 |
Why?
|
| Central Nervous System Diseases | 1 | 2024 | 58 | 0.050 |
Why?
|
| Microscopy | 1 | 2024 | 94 | 0.050 |
Why?
|
| X-Rays | 1 | 2022 | 46 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2022 | 23 | 0.050 |
Why?
|
| Simvastatin | 1 | 2022 | 26 | 0.050 |
Why?
|
| Proof of Concept Study | 1 | 2022 | 38 | 0.050 |
Why?
|
| Computed Tomography Angiography | 1 | 2023 | 129 | 0.050 |
Why?
|
| Exons | 1 | 2023 | 201 | 0.050 |
Why?
|
| Reflex | 1 | 2021 | 27 | 0.050 |
Why?
|
| Arginine | 1 | 2022 | 131 | 0.040 |
Why?
|
| Radiography, Interventional | 1 | 2022 | 81 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2022 | 103 | 0.040 |
Why?
|
| Astrocytes | 1 | 2021 | 121 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 397 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2026 | 2482 | 0.040 |
Why?
|
| Mammography | 1 | 2022 | 290 | 0.040 |
Why?
|
| Sheep | 1 | 2020 | 182 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 321 | 0.040 |
Why?
|
| Cognition | 1 | 2022 | 491 | 0.040 |
Why?
|
| Cuprizone | 1 | 2018 | 3 | 0.030 |
Why?
|
| Remyelination | 1 | 2018 | 3 | 0.030 |
Why?
|
| PPAR delta | 1 | 2018 | 10 | 0.030 |
Why?
|
| Quetiapine Fumarate | 1 | 2018 | 13 | 0.030 |
Why?
|
| Demyelinating Diseases | 1 | 2018 | 15 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2023 | 2138 | 0.030 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2017 | 8 | 0.030 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2017 | 34 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2017 | 192 | 0.030 |
Why?
|
| Neurons | 1 | 2021 | 934 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 225 | 0.030 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 71 | 0.030 |
Why?
|
| Antipsychotic Agents | 1 | 2018 | 304 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2014 | 75 | 0.030 |
Why?
|
| Metal Nanoparticles | 1 | 2015 | 188 | 0.020 |
Why?
|
| Models, Biological | 1 | 2017 | 1187 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1622 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 1029 | 0.020 |
Why?
|